Infectious Disease Diagnostics Market
SHARE
PUBLISHED: 2022 ID: SMRC21792
SHARE

Infectious Disease Diagnostics Market Forecasts to 2028 – Global Analysis By Technique (Traditional, Molecular), End User (Hospitals & Clinics, Diagnostic Reference Laboratories, Academic Research Institutes) and By Geography

4.2 (98 reviews)
4.2 (98 reviews)
Published: 2022 ID: SMRC21792

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $30.69 billion in 2022 and is expected to reach $52.03 billion by 2028 growing at a CAGR of 9.2% during the forecast period. Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. The infectious disease epidemics are exploding worldwide, raising an extensive demand for diagnostic tests.

In 2020, molecular technologies accounted for approximately 49 percent of the worldwide organ transplant diagnostics market. This was followed by serology which had a 30 percent market share. By 2031, it was forecast that the market share of molecular technologies would increase to just under 54 percent. In 2020, PCR accounted for approximately 42.7 percent of the worldwide molecular diagnostics market, while next-generation sequencing amounted to 10.4 percent of the market. By 2031, PCR was forecast to have a 43.3 percent share of the molecular diagnostics market.

Market Dynamics:

Driver:

Rising prevalence of infectious diseases

The prevalence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period. The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics. Hence, it is expected to have a positive impact on this market.

Restraint:

Inadequate reimbursement

Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

Opportunity:

Opportunities from developing economies

Developing economies such as India and South Korea are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements.

Threat:

Poor distribution channel

Diagnostic kits are expensive and manufacturers still have poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

Covid-19 Impact

Diagnostics for SARS-CoV-2 screening are being developed continuously to cater to the needs of markets with unique regulatory constraints. For example, in November 2021, Detect, a health technology firm, launched a new PCR-quality at-home Covid-19 quick molecular test to address testing needs at home, school, and work, in the United States. Likewise, CoviSwift, by Mylab Discovery Solutions, a point-of-care (POC) RT-PCR testing solution that may be utilized in small labs, in-hospital labs, airports, and communities, was approved and launched in February 2022. Similarly, Abbott introduced the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, in March 2020, and BioMedomics released a PoC COVID-19 test that can identify antibodies in blood within 15 minutes in March 2020.

The reagents, kits, and consumables segment is expected to be the largest during the forecast period

The reagents, kits, and consumables segment is expected to be the largest during the forecast period owing to the factors such as increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost. Further, the outbreak of coronavirus (COVID-19) disease is further expected to accelerate the growth of this segment owing to the national emergency declared and requirement of various kits and assays for early disease detection.
 
The traditional segment is expected to have the highest CAGR during the forecast period

The dominance of traditional segment is mainly attributed to factors such as the increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments.

Region with largest share:

North America is projected to hold the largest market share owing to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments. Other factors contributing to the market growth are the increasing prevalence of infectious diseases and high expenditure on healthcare, and an increase in awareness among the population regarding the availability of treatment devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Key players in the market

Some of the key players profiled in the Infectious Disease Diagnostics Market include Becton, Dickinson and Company (BD), Abbott Diagnostic, Beckman Coulter, Siemens Healthcare Diagnostics, Roche Diagnostic, Thermo Fisher Scientific, Bio-Rad Laboratories, Meridian Bioscience, Corgenix, Trinity Biotech, Eiken Chemical, J.Mitra, Diasorin, EMD Millipore, and QuantuMDx. 

Key developments:

In July 2021: QuantuMDx launched the rapid polymerase chain reaction point-of-care diagnostic system called Q-POC for COVID-19.

In March 2021: Roche Diagnostics Launched cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.

In February 2021: Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

Products Covered:
• Reagents, Kits, and Consumables
• Instruments & Systems
• Software & Services

Test Types Covered:
• Laboratory Tests
• Imaging Test
• Point-of-Care (POC) Testing

Disease Types Covered:
• Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))
• Viral Infection
• Hepatitis C
• Hepatitis B
• Cardiovascular Infection
• Fungal Infection
• Hospital Acquired Infections (HAIs)
• Respiratory Infections
• Blood Infections
• Diarrheal Disease
• Central Nervous System (CNS) Infection
• Sexually Transmitted Diseases

Techniques Covered:
• Traditional
• Molecular

End Users Covered:
• Hospitals & Clinics
• Diagnostic Reference Laboratories
• Academic Research Institutes
• Home Healthcare
• Physician Offices
• Contract Research Organization
• Surgical Centers

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

Table of Contents

1 Executive Summary        
          
2 Preface         
 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology      
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources        
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions      
          
3 Market Trend Analysis       
 3.1 Introduction       
 3.2 Drivers        
 3.3 Restraints        
 3.4 Opportunities       
 3.5 Threats        
 3.6 Product Analysis       
 3.7 End User Analysis       
 3.8 Emerging Markets       
 3.9 Impact of Covid-19       
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes       
 4.4 Threat of new entrants      
 4.5 Competitive rivalry       
          
5 Global Infectious Disease Diagnostics Market, By Product    
 5.1 Introduction       
 5.2 Reagents, Kits, and Consumables     
 5.3 Instruments & Systems      
 5.4 Software & Services       
          
6 Global Infectious Disease Diagnostics Market, By Test Type    
 6.1 Introduction       
 6.2 Laboratory Tests       
  6.2.1 Blood Test      
  6.2.2 Stool Test       
  6.2.3 Urine Test      
  6.2.4 Spinal Tap      
  6.2.5 Throat Swabs      
 6.3 Imaging Test       
  6.3.1 Computed tomography (CT)     
  6.3.2 Magnetic Resonance Imaging (MRI)    
  6.3.3 X-ray       
  6.3.4 Biopsies       
 6.4 Point-of-Care (POC) Testing      
          
7 Global Infectious Disease Diagnostics Market, By Disease Type    
 7.1 Introduction       
 7.2 Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))  
 7.3 Viral Infection       
  7.3.1 COVID-19       
  7.3.2 Human Papillomavirus (HPV)     
 7.4 Hepatitis C       
 7.5 Hepatitis B       
 7.6 Cardiovascular Infection      
 7.7 Fungal Infection       
 7.8 Hospital Acquired Infections (HAIs)     
 7.9 Respiratory Infections      
  7.9.1 Tuberculosis      
  7.9.2 Bronchitis       
  7.9.3 Influenza       
 7.10 Blood Infections       
  7.10.1 Infectious Mononucleosis     
  7.10.2 Malaria        
  7.10.3 Dengue       
 7.11 Diarrheal Disease       
  7.11.1 Enteric/Typhoid Fever     
  7.11.2 Cholera       
  7.11.3 Shigellosis      
 7.12 Central Nervous System (CNS) Infection     
  7.12.1 Brain Abscess      
  7.12.2 Meningitis      
 7.13 Sexually Transmitted Diseases      
  7.13.1 Syphilis       
  7.13.2 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) 
  7.13.3 Acquired Immunodeficiency Syndrome (AIDS)   
          
8 Global Infectious Disease Diagnostics Market, By Technique    
 8.1 Introduction       
 8.2 Traditional       
  8.2.1 Gram-stain Pathogen Culturing     
  8.2.2 Enzyme Immunoassay Agglutination    
  8.2.3 Biochemical Characterization     
  8.2.4 Immunodiagnostics      
  8.2.5 Microscopy      
 8.3 Molecular       
  8.3.1 Clinical Microbiology      
  8.3.2 Isothermal Nucleic Acid Amplification Test (INAAT)   
  8.3.3 Polymerase Chain Reaction (PCR)    
  8.3.4 Microarrays      
  8.3.5 Hybridization      
  8.3.6 Next-generation Sequencing (NGS) & Deoxyribonucleic Acid (DNA) Sequencing
          
9 Global Infectious Disease Diagnostics Market, By End User    
 9.1 Introduction       
 9.2 Hospitals & Clinics       
 9.3 Diagnostic Reference Laboratories     
 9.4 Academic Research Institutes      
 9.5 Home Healthcare       
 9.6 Physician Offices        
 9.7 Contract Research Organization      
 9.8 Surgical Centers       
          
10 Global Infectious Disease Diagnostics Market, By Geography    
 10.1 Introduction       
 10.2 North America       
  10.2.1 US       
  10.2.2 Canada       
  10.2.3 Mexico       
 10.3 Europe        
  10.3.1 Germany       
  10.3.2 UK       
  10.3.3 Italy       
  10.3.4 France       
  10.3.5 Spain       
  10.3.6 Rest of Europe      
 10.4 Asia Pacific       
  10.4.1 Japan       
  10.4.2 China        
  10.4.3 India       
  10.4.4 Australia       
  10.4.5 New Zealand      
  10.4.6 South Korea      
  10.4.7 Rest of Asia Pacific      
 10.5 South America       
  10.5.1 Argentina       
  10.5.2 Brazil       
  10.5.3 Chile       
  10.5.4 Rest of South America     
 10.6 Middle East & Africa       
  10.6.1 Saudi Arabia      
  10.6.2 UAE       
  10.6.3 Qatar       
  10.6.4 South Africa      
  10.6.5 Rest of Middle East & Africa     
          
11 Key Developments        
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 11.2 Acquisitions & Mergers      
 11.3 New Product Launch       
 11.4 Expansions       
 11.5 Other Key Strategies       
          
12 Company Profiling        
 12.1 Becton, Dickinson and Company (BD)     
 12.2 Abbott Diagnostic         
 12.3 Beckman Coulter         
 12.4 Siemens Healthcare Diagnostics      
 12.5 Roche Diagnostic       
 12.6 Thermo Fisher Scientific       
 12.7 Bio-Rad Laboratories       
 12.8 Meridian Bioscience       
 12.9 Corgenix        
 12.10 Trinity Biotech       
 12.11 Eiken Chemical        
 12.12 J.Mitra        
 12.13 Diasorin         
 12.14 EMD Millipore       
 12.15 QuantuMDx       
          
List of Tables         
1 Global Infectious Disease Diagnostics Market Outlook, By Region (2020-2028) ($MN)  
2 Global Infectious Disease Diagnostics Market Outlook, By Product (2020-2028) ($MN)  
3 Global Infectious Disease Diagnostics Market Outlook, By Reagents, Kits, and Consumables (2020-2028) ($MN)
4 Global Infectious Disease Diagnostics Market Outlook, By Instruments & Systems (2020-2028) ($MN)
5 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2020-2028) ($MN) 
6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)  
7 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2020-2028) ($MN) 
8 Global Infectious Disease Diagnostics Market Outlook, By Blood Test (2020-2028) ($MN) 
9 Global Infectious Disease Diagnostics Market Outlook, By Stool Test (2020-2028) ($MN) 
10 Global Infectious Disease Diagnostics Market Outlook, By Urine Test (2020-2028) ($MN) 
11 Global Infectious Disease Diagnostics Market Outlook, By Spinal Tap (2020-2028) ($MN) 
12 Global Infectious Disease Diagnostics Market Outlook, By Throat Swabs (2020-2028) ($MN) 
13 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2020-2028) ($MN) 
14 Global Infectious Disease Diagnostics Market Outlook, By Computed tomography (CT) (2020-2028) ($MN)
15 Global Infectious Disease Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2020-2028) ($MN)
16 Global Infectious Disease Diagnostics Market Outlook, By X-ray (2020-2028) ($MN)  
17 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2020-2028) ($MN)  
18 Global Infectious Disease Diagnostics Market Outlook, By Point-of-Care (POC) Testing (2020-2028) ($MN)
19 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2020-2028) ($MN) 
20 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA)) (2020-2028) ($MN)
21 Global Infectious Disease Diagnostics Market Outlook, By Viral Infection (2020-2028) ($MN) 
22 Global Infectious Disease Diagnostics Market Outlook, By COVID-19 (2020-2028) ($MN) 
23 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2020-2028) ($MN)
24 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis C (2020-2028) ($MN) 
25 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis B (2020-2028) ($MN) 
26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular Infection (2020-2028) ($MN)
27 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infection (2020-2028) ($MN) 
28 Global Infectious Disease Diagnostics Market Outlook, By Hospital Acquired Infections (HAIs) (2020-2028) ($MN)
29 Global Infectious Disease Diagnostics Market Outlook, By Respiratory Infections (2020-2028) ($MN)
30 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (2020-2028) ($MN) 
31 Global Infectious Disease Diagnostics Market Outlook, By Bronchitis (2020-2028) ($MN) 
32 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2020-2028) ($MN)  
33 Global Infectious Disease Diagnostics Market Outlook, By Blood Infections (2020-2028) ($MN) 
34 Global Infectious Disease Diagnostics Market Outlook, By Infectious Mononucleosis (2020-2028) ($MN)
35 Global Infectious Disease Diagnostics Market Outlook, By Malaria (2020-2028) ($MN)  
36 Global Infectious Disease Diagnostics Market Outlook, By Dengue (2020-2028) ($MN)  
37 Global Infectious Disease Diagnostics Market Outlook, By Diarrheal Disease (2020-2028) ($MN) 
38 Global Infectious Disease Diagnostics Market Outlook, By Enteric/Typhoid Fever (2020-2028) ($MN)
39 Global Infectious Disease Diagnostics Market Outlook, By Cholera (2020-2028) ($MN)  
40 Global Infectious Disease Diagnostics Market Outlook, By Shigellosis (2020-2028) ($MN) 
41 Global Infectious Disease Diagnostics Market Outlook, By Central Nervous System (CNS) Infection (2020-2028) ($MN)
42 Global Infectious Disease Diagnostics Market Outlook, By Brain Abscess (2020-2028) ($MN) 
43 Global Infectious Disease Diagnostics Market Outlook, By Meningitis (2020-2028) ($MN) 
44 Global Infectious Disease Diagnostics Market Outlook, By Sexually Transmitted Diseases (2020-2028) ($MN)
45 Global Infectious Disease Diagnostics Market Outlook, By Syphilis (2020-2028) ($MN)  
46 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2020-2028) ($MN)
47 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2020-2028) ($MN)
48 Global Infectious Disease Diagnostics Market Outlook, By Technique (2020-2028) ($MN) 
49 Global Infectious Disease Diagnostics Market Outlook, By Traditional (2020-2028) ($MN) 
50 Global Infectious Disease Diagnostics Market Outlook, By Gram-stain Pathogen Culturing (2020-2028) ($MN)
51 Global Infectious Disease Diagnostics Market Outlook, By Enzyme Immunoassay Agglutination (2020-2028) ($MN)
52 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2020-2028) ($MN)
53 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2020-2028) ($MN) 
54 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2020-2028) ($MN) 
55 Global Infectious Disease Diagnostics Market Outlook, By Molecular (2020-2028) ($MN) 
56 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2020-2028) ($MN)
57 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Test (INAAT) (2020-2028) ($MN)
58 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2020-2028) ($MN)
59 Global Infectious Disease Diagnostics Market Outlook, By Microarrays (2020-2028) ($MN) 
60 Global Infectious Disease Diagnostics Market Outlook, By Hybridization (2020-2028) ($MN) 
61 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (NGS) & Deoxyribonucleic Acid (DNA) Sequencing (2020-2028) ($MN)
62 Global Infectious Disease Diagnostics Market Outlook, By End User (2020-2028) ($MN)  
63 Global Infectious Disease Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN) 
64 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Reference Laboratories (2020-2028) ($MN)
65 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2020-2028) ($MN)
66 Global Infectious Disease Diagnostics Market Outlook, By Home Healthcare (2020-2028) ($MN) 
67 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2020-2028) ($MN) 
68 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2020-2028) ($MN)
69 Global Infectious Disease Diagnostics Market Outlook, By Surgical Centers (2020-2028) ($MN) 
          
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

 

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials